NAVREF is proud to recognize Cohen Veterans Bioscience as our Champion Sponsor
CURRENT IPC MEMBERS
Cohen Veterans Bioscience
As the only association working closely with the Department of Veterans Affairs' research, NAVREF bridges the gap between industry partners and our unique membership of VA-Affiliated Nonprofit Research and Education Foundations. These foundations provide a conduit to the largest and most deserving patient base in the United States. However, there are veterans in search of cutting edge healthcare that are faced with obstacles in need of change. This is where the NAVREF Industry Partner Consortium plays a role.
The NAVREF Industry Partner Consortium (IPC) is a platform for industry sponsors, nonprofit organizations, and other external stakeholders to identify, collaborate, and overcome challenges within VA research that hinder our nation's veterans from accessing some of the finest and most cutting edge healthcare available. The IPC represents stakeholders from all facets of the healthcare industry representing pharmaceuticals, medical technology, nonprofit foundations, and other organizations with an interest to further veterans research.
Interested in the IPC?
IPC Membership is annual and begins at the beginning of the calendar year (January 1). Organizations interested in joining the IPC can fill out a membership application found below.
Click for the IPC Application Packet
The IPC Mission and Charter
Born from the ACT for Veterans Initiative (Access to Clinical Trials), the Industry Partner Consortium was established to tackle the challenges facing industry partners from delivering quality clinical trials to our nations' veterans.
The mission is to provide a platform to identify barriers and develop solutions facing veterans' access to clinical trials through the collaboration of industry sponsors, nonprofit organizations, and other stake holders interested in supporting VA Research.
The full IPC Charter can be found here.
IPC News and Updates
The members intend to conduct their affairs in compliance with the antitrust laws of the United States, the states within the United States and the antitrust/competition laws of other countries. The representatives will not: